Patents by Inventor Daniel W. Goodman

Daniel W. Goodman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment for Attention-Deficit Hyperactivity Disorder
    Publication number: 20120070494
    Abstract: A method for treating Attention Deficit/Hyperactivity Disorder (ADHD) in humans and the symptoms associated therewith, inattentiveness, and hyperactivity with impulsivity, using eltoprazine and related compounds is provided.
    Type: Application
    Filed: August 16, 2011
    Publication date: March 22, 2012
    Applicant: Psychogenics, Inc.
    Inventors: Daniela Brunner, Daniel W. Goodman
  • Treatment for Attention-Deficit Hyperactivity Disorder
    Publication number: 20110008425
    Abstract: A method for treating Attention Deficit/Hyperactivity Disorder (ADHD) in humans and the symptoms associated therewith, inattentiveness, and hyperactivity with impulsivity, using eltoprazine and related compounds is provided.
    Type: Application
    Filed: September 20, 2010
    Publication date: January 13, 2011
    Applicant: Psychogenics, Inc.
    Inventors: Daniela Brunner, Daniel W. Goodman
  • Analogues of lipid mediators derived from ?-3 PUFAs and methods of use
    Patent number: 7595341
    Abstract: The present invention is directed to compounds that are analogues of lipid mediators derived from a fish oil-derived fatty acid, eicosapentaenoic acid [C20:5 ?-3; EPA], but with a longer tissue half-life and enhanced bioactivity. These analogues may be used to treat inflammatory, angioproliferative, cardiovascular, thrombophlebotic, vascular, ocular, dermatologic, neurodegenerative, pulmonary, endocrine, reproductive, rheumatologic and gastrointestinal diseases.
    Type: Grant
    Filed: April 30, 2008
    Date of Patent: September 29, 2009
    Assignees: Resolvyx Pharmacuticals, Inc., The Brigham and Women's Hospital
    Inventors: Daniel W. Goodman, Michael R. Hanley, Stuart L. Bursten, Charles N. Serhan
  • Treatment for attention-deficit hyperactivity disorder
    Patent number: 7557109
    Abstract: A method for treating Attention Deficit/Hyperactivity Disorder (ADHD) in humans and the symptoms associated therewith, inattentiveness, and hyperactivity with impulsivity, using eltoprazine and related compounds is provided.
    Type: Grant
    Filed: September 2, 2005
    Date of Patent: July 7, 2009
    Assignee: Psychogenics, Inc.
    Inventors: Daniela Brunner, Daniel W. Goodman
  • Treatment for Attention-Deficit Hyperactivity Disorder
    Publication number: 20090104261
    Abstract: A method for treating Attention Deficit/Hyperactivity Disorder (ADHD) in humans and the symptoms associated therewith, inattentiveness, and hyperactivity with impulsivity, using eltoprazine and related compounds is provided.
    Type: Application
    Filed: December 24, 2008
    Publication date: April 23, 2009
    Applicant: Psychogenics, Inc.
    Inventors: Daniela Brunner, Daniel W. Goodman
  • Treatment for attention-deficit hyperactivity disorder
    Patent number: 7504395
    Abstract: A method for treating Attention Deficit/Hyperactivity Disorder (ADHD) in humans and the symptoms associated therewith, inattentiveness, and hyperactivity with impulsivity, using eltoprazine and related compounds is provided.
    Type: Grant
    Filed: July 19, 2002
    Date of Patent: March 17, 2009
    Assignee: Psychogenics, Inc.
    Inventors: Daniela Brunner, Daniel W. Goodman
  • Analogues of lipid mediators derived from omega-3 PUFAs and methods of use
    Publication number: 20080207753
    Abstract: The present invention is directed to compounds that are analogues of lipid mediators derived from a fish oil-derived fatty acid, eicosapentaenoic acid [C20:5 ?-3; EPA], but with a longer tissue half-life and enhanced bioactivity. These analogues may be used to treat inflammatory, angioproliferative, cardiovascular, thrombophlebotic, vascular, ocular, dermatologic, neurodegenerative, pulmonary, endocrine, reproductive, rheumatologic and gastrointestinal diseases.
    Type: Application
    Filed: April 30, 2008
    Publication date: August 28, 2008
    Applicants: Resolvyx Pharmaceuticals, Inc., The Brigham and Women's Hospital, Inc.
    Inventors: Daniel W. Goodman, Michael R. Hanley, Stuart L. Bursten, Charles N. Serhan
  • Analogues of lipid mediators derived from omega-3 PUFAs and methods of use
    Patent number: 7378444
    Abstract: The present invention is directed to compounds that are analogues of lipid mediators derived from a fish oil-derived fatty acid, eicosapentaenoic acid [C20:5 ?-3; EPA], but with a longer tissue half-life and enhanced bioactivity. These analogues may be used to treat inflammatory, angioproliferative, cardiovascular, thrombophlebotic, vascular, ocular, dermatologic, neurodegenerative, pulmonary, endocrine, reproductive, rheumatologic and gastrointestinal diseases.
    Type: Grant
    Filed: June 13, 2003
    Date of Patent: May 27, 2008
    Assignees: Brigham and Women's Hospital, Inc., Resolvyx Pharmaceuticals, Inc.
    Inventors: Daniel W. Goodman, Michael R. Hanley, Stuart L. Bursten, Charles N. Serhan
  • Analogues of lipid mediators derived from omega-3 PUFAs and methods of use
    Publication number: 20040044050
    Abstract: The present invention is directed to compounds that are analogues of lipid mediators derived from a fish oil-derived fatty acid, eicosapentaenoic acid [C20:5 &ohgr;-3; EPA], but with a longer tissue half-life and enhanced bioactivity. These analogues may be used to treat inflammatory, angioproliferative, cardiovascular, thrombophlebotic, vascular, ocular, dermatologic, neurodegenerative, pulmonary, endocrine, reproductive, rheumatologic and gastrointestinal diseases.
    Type: Application
    Filed: June 13, 2003
    Publication date: March 4, 2004
    Inventors: Daniel W. Goodman, Michael R. Hanley, Stuart L. Bursten
  • Treatment for attention-deficit hyperactivity disorder
    Publication number: 20030050308
    Abstract: A method for treating Attention Deficit/Hyperactivity Disorder (ADHD) in humans and the symptoms associated therewith, inattentiveness, and hyperactivity with impulsivity, using eltoprazine and related compounds is provided.
    Type: Application
    Filed: July 19, 2002
    Publication date: March 13, 2003
    Inventors: Daniela Brunner, Daniel W. Goodman